Baird Medical Investment Holdings Limited (BDMD) — Cash Flow Reinvestment Rate
Baird Medical Investment Holdings Limited (BDMD) has a Cash Flow Reinvestment Rate of 1.97x as of June 2023, reinvesting $1.26 Million (capex $1.26 Million ) from operating cash flow of $642.95K. See free cash flow generation of Baird Medical Investment Holdings Limite to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Baird Medical Investment Holdings Limited Cash Flow Reinvestment Rate (2019–2022)
Historical reinvestment intensity for Baird Medical Investment Holdings Limited across 4 annual periods. For the full cash flow conversion analysis, see BDMD cash flow conversion.
Annual Cash Flow Reinvestment Rate for Baird Medical Investment Holdings Limited (2019–2022)
Year-by-year capital reinvestment analysis for Baird Medical Investment Holdings Limited. See financial agility of Baird Medical Investment Holdings Limite to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 24.44x | $11.88 Million | $485.97K | $5.95 Million | ▲ +4528.2% |
| 2021 | 0.53x | $2.77 Million | $5.26 Million | $1.39 Million | ▲ +214.8% |
| 2020 | 0.17x | $655.35K | $3.91 Million | $655.35K | ▼ -24.8% |
| 2019 | 0.22x | $983.78K | $4.41 Million | $983.78K | — |